Cargando…

Rapidly increasing cumulative incidence of coronavirus disease (COVID-19) in the European Union/European Economic Area and the United Kingdom, 1 January to 15 March 2020

The cumulative incidence of coronavirus disease (COVID-19) cases is showing similar trends in European Union/European Economic Area countries and the United Kingdom confirming that, while at a different stage depending on the country, the COVID-19 pandemic is progressing rapidly in all countries. Ba...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kinross, Pete, Suetens, Carl, Gomes Dias, Joana, Alexakis, Leonidas, Wijermans, Ariana, Colzani, Edoardo, Monnet, Dominique L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Centre for Disease Prevention and Control (ECDC) 2020
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096777/ https://www.ncbi.nlm.nih.gov/pubmed/32186277 http://dx.doi.org/10.2807/1560-7917.ES.2020.25.11.2000285

Ejemplares similares

Potential scenarios for the progression of a COVID-19 epidemic in the European Union and the European Economic Area, March 2020
por: Johnson, Helen C, et al.
Publicado: (2020)

Candida auris: epidemiological situation, laboratory capacity and preparedness in the European Union and European Economic Area*, January 2018 to May 2019
por: Plachouras, Diamantis, et al.
Publicado: (2020)

Candida auris: epidemiological situation, laboratory capacity and preparedness in European Union and European Economic Area countries, 2013 to 2017
por: Kohlenberg, Anke, et al.
Publicado: (2018)

Decreasing and stabilising trends of antimicrobial consumption and resistance in Escherichia coli and Klebsiella pneumoniae in segmented regression analysis, European Union/European Economic Area, 2001 to 2018
por: Peñalva, Germán, et al.
Publicado: (2019)

Reduction in undiagnosed HIV infection in the European Union/European Economic Area, 2012 to 2016
por: van Sighem, Ard, et al.
Publicado: (2017)

Rapid cross-border emergence of NDM-5-producing Escherichia coli in the European Union/European Economic Area, 2012 to June 2022
por: Linkevicius, Marius, et al.
Publicado: (2023)

Will we reach the Sustainable Development Goals target for tuberculosis in the European Union/European Economic Area by 2030?
por: Merk, Hanna, et al.
Publicado: (2019)

Monitoring the progress achieved towards ending tuberculosis in the European Union/European Economic Area, 2018 to 2021
por: Cristea, Veronica, et al.
Publicado: (2023)

Healthcare-associated pneumonia in acute care hospitals in European Union/European Economic Area countries: an analysis of data from a point prevalence survey, 2011 to 2012
por: Walter, Jan, et al.
Publicado: (2018)

Estimating HIV incidence and number of undiagnosed individuals living with HIV in the European Union/European Economic Area, 2015
por: Pharris, Anastasia, et al.
Publicado: (2016)

Health crisis in Venezuela: Status of communicable diseases and implications for the European Union and European Economic Area, May 2019
por: Espinosa, Laura, et al.
Publicado: (2019)

Human papillomavirus vaccination in the European Union/European Economic Area and globally: a moral dilemma
por: Colzani, Edoardo, et al.
Publicado: (2021)

Increasing risk of breakthrough COVID-19 in outbreaks with high attack rates in European long-term care facilities, July to October 2021
por: Suetens, Carl, et al.
Publicado: (2021)

Risk of hospitalization and death for healthcare workers with COVID-19 in nine European countries, January 2020–January 2021
por: Ferland, L., et al.
Publicado: (2022)

Livestock-associated meticillin-resistant Staphylococcus aureus (MRSA) among human MRSA isolates, European Union/European Economic Area countries, 2013
por: Kinross, Pete, et al.
Publicado: (2017)

Measles outbreak linked to European B3 outbreaks, Wales, United Kingdom, 2017
por: Currie, Jonny, et al.
Publicado: (2017)

Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019
por: Kissling, Esther, et al.
Publicado: (2019)

Increased risk of yellow fever infections among unvaccinated European travellers due to ongoing outbreak in Brazil, July 2017 to March 2018
por: Gossner, Céline M, et al.
Publicado: (2018)

Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020
por: Alm, Erik, et al.
Publicado: (2020)

An increase in reports of acute flaccid paralysis (AFP) in the United Kingdom, 1 January 2018–21 January 2019: early findings
Publicado: (2019)

Insights into the primate trade into the European Union and the United Kingdom
por: Svensson, Magdalena S., et al.
Publicado: (2023)

First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020
por: Spiteri, Gianfranco, et al.
Publicado: (2020)

Impact of the COVID-19 pandemic on tuberculosis national reference laboratory services in the WHO European Region, March to November 2020
por: Maurer, Florian P, et al.
Publicado: (2021)

Introductions and early spread of SARS-CoV-2 in France, 24 January to 23 March 2020
por: Gámbaro, Fabiana, et al.
Publicado: (2020)

A large multi-country outbreak of monkeypox across 41 countries in the WHO European Region, 7 March to 23 August 2022
por: Vaughan, Aisling M, et al.
Publicado: (2022)

Indications for healthcare surge capacity in European countries facing an exponential increase in coronavirus disease (COVID-19) cases, March 2020
por: Verelst, Frederik, et al.
Publicado: (2020)

Antimicrobial use in European long-term care facilities: results from the third point prevalence survey of healthcare-associated infections and antimicrobial use, 2016 to 2017
por: Ricchizzi, Enrico, et al.
Publicado: (2018)

Need for additional capacity and improved capability for molecular detection of yellow fever virus in European Expert Laboratories: External Quality Assessment, March 2018
por: Domingo, Cristina, et al.
Publicado: (2018)

Impact of the COVID-19 pandemic on testing services for HIV, viral hepatitis and sexually transmitted infections in the WHO European Region, March to August 2020
por: Simões, Daniel, et al.
Publicado: (2020)

Consumption of cephalosporins in the community, European Union/European Economic Area, 1997–2017
por: Versporten, Ann, et al.
Publicado: (2021)

Consumption of quinolones in the community, European Union/European Economic Area, 1997–2017
por: Adriaenssens, Niels, et al.
Publicado: (2021)

Consumption of penicillins in the community, European Union/European Economic Area, 1997–2017
por: Bruyndonckx, Robin, et al.
Publicado: (2021)

Consumption of antibiotics in the community, European Union/European Economic Area, 1997–2017
por: Bruyndonckx, Robin, et al.
Publicado: (2021)

Austerity and Abortion in the European Union
por: Lima, Joana Madureira, et al.
Publicado: (2016)

Breast cancer in European Union: An update of screening programmes as of March 2014 (Review)
por: ALTOBELLI, E., et al.
Publicado: (2014)

COVID-19 trends and severity among symptomatic children aged 0–17 years in 10 European Union countries, 3 August 2020 to 3 October 2021
por: Bundle, Nick, et al.
Publicado: (2021)

Ongoing outbreaks of hepatitis A among men who have sex with men (MSM), Berlin, November 2016 to January 2017 – linked to other German cities and European countries
por: Werber, Dirk, et al.
Publicado: (2017)

Antimicrobial use in European acute care hospitals: results from the second point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use, 2016 to 2017
por: Plachouras, Diamantis, et al.
Publicado: (2018)

Ongoing large measles outbreak with nosocomial transmission in Milan, northern Italy, March–August 2017
por: Amendola, Antonella, et al.
Publicado: (2017)

Consumption of macrolides, lincosamides and streptogramins in the community, European Union/European Economic Area, 1997–2017
por: Adriaenssens, Niels, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gv2bnpd04ltb2n7f9svh3i7vcq